PM1183 Ha Aportado hasta el Momento unos Resultados Nunca Vistos en los últimos 17 Años en todos los Pacientes con Cáncer de Pulmón ( SCLC ) Tratados en el Ensayo . Medicines For The Modern World .

Novel Small-Cell Lung Cancer Treatments are still lacking, and it has been 17 years since the last New Drug Approval for this strain of the illness” .

... PM1183 used in Combination with Chemotherapy Managed to Stimulate a Response from all the Patients in an early-stage trial . Such a result had been previously unheard of in a Small-Cell Lung Cancer Patient Population.

...